| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 10 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 31.414 | 36.596 | 3.164 | 4.659 |
| Total Expenses - EUR | - | - | - | - | - | - | 32.759 | 51.994 | 28.713 | 4.764 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.345 | -15.397 | -25.550 | -105 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.345 | -15.397 | -25.550 | -105 |
| Employees | - | - | - | - | - | - | 5 | 5 | 3 | 0 |
Check the financial reports for the company - Bioline Lux S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 23.340 | 19.311 | 12.288 | 7.560 |
| Current Assets | - | - | - | - | - | - | 39.678 | 730 | -21 | -125 |
| Inventories | - | - | - | - | - | - | 0 | 4 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 22.987 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | - | 16.691 | 726 | -21 | -125 |
| Shareholders Funds | - | - | - | - | - | - | -1.304 | -16.706 | -42.205 | -33.506 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.790 | 12.607 | 33.569 | 33.381 |
| Income in Advance | - | - | - | - | - | - | 60.532 | 24.140 | 20.903 | 7.559 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bioline Lux S.r.l.